We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENJY
4526
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$10K ﹤0.01%
+47,981
New +$56.1K
LBPH
4527
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$10K ﹤0.01%
3,146
+2,918
+1,280% +$13.4K
CWBC
4528
DELISTED
Community West BanCshares
CWBC
$10K ﹤0.01%
638
+35
+6% +$485
TSRI
4529
DELISTED
TSR Inc. New
TSRI
$10K ﹤0.01%
1,376
+674
+96% +$5.61K
ABEO icon
4530
Abeona Therapeutics
ABEO
$425M
$9K ﹤0.01%
1,730
+1,577
+1,031% +$7.98K
ACIU icon
4531
AC Immune
ACIU
$267M
$9K ﹤0.01%
2,412
-5,245
-68% -$17.9K
ZNB
4532
Zeta Network Group
ZNB
$2.27M
– –
0
– –
ADIL
4533
Adial Pharmaceuticals
ADIL
$9.43M
$9K ﹤0.01%
11
+3
+38% +$2.72K
AWX icon
4534
Avalon Holdings
AWX
$10.7M
$9K ﹤0.01%
3,537
+1,118
+46% +$3.48K
BB icon
4535
BlackBerry
BB
$5.27B
$9K ﹤0.01%
1,582
-37,745
-96% -$224K
BBLG
4536
Bone Biologics
BBLG
$1.22M
$9K ﹤0.01%
+4
New +$10.6K
BGSF icon
4537
BGSF Inc
BGSF
$57.6M
$9K ﹤0.01%
696
-2,335
-77% -$29.2K
BLIN icon
4538
Bridgeline Digital
BLIN
$13.7M
$9K ﹤0.01%
7,504
+3,746
+100% +$5.32K
BZFD icon
4539
BuzzFeed
BZFD
$92.5M
$9K ﹤0.01%
1,386
+913
+193% +$13.8K
CEPU
4540
Central Puerto
CEPU
$1.99B
$9K ﹤0.01%
+2,840
New +$10.3K
PRHI
4541
Presurance Holdings
PRHI
$15.4M
$9K ﹤0.01%
791
+517
+189% +$6.89K
CRVS icon
4542
Corvus Pharmaceuticals
CRVS
$1.27B
$9K ﹤0.01%
9,333
+6,361
+214% +$7.8K
CSPI icon
4543
CSP Inc
CSPI
$83.3M
$9K ﹤0.01%
1,906
-588
-24% -$2.36K
HELP
4544
Cybin Inc
HELP
$710M
$9K ﹤0.01%
403
+269
+201% +$6.52K
AXIA
4545
DELISTED
AXIA Energia
AXIA
$9K ﹤0.01%
+1,293
New +$8.72K
EBTC
4546
DELISTED
Enterprise Bancorp
EBTC
$9K ﹤0.01%
288
-5,043
-95% -$172K
EGAN icon
4547
eGain
EGAN
$200M
$9K ﹤0.01%
880
-8,167
-90% -$81.4K
ELMD icon
4548
Electromed
ELMD
$352M
$9K ﹤0.01%
960
-100
-9% -$1.18K
ENVB icon
4549
Enveric Biosciences
ENVB
$6.24M
$9K ﹤0.01%
5
+3
+150% +$6.38K
EP icon
4550
Empire Petroleum
EP
$108M
$9K ﹤0.01%
+719
New +$14.4K
180 181
182
183 184

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.